Bio Preventive Medicine (ROCO:6810) Tariff Resilience Score: 0/10 (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6810 Bio Preventive Medicine Corp ROCO:6810
52 GF Score
Price NT$21.00
GF Value NT$27.53
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bio Preventive Medicine Tariff Resilience Score?

Bio Preventive Medicine has the Tariff Resilience Score of 0, which implies that the company might have .

Bio Preventive Medicine has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Bio Preventive Medicine might have .


Bio Preventive Medicine  (ROCO:6810) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Bio Preventive Medicine Tariff Resilience Score Related Terms

ROCO:6810
52GF Score
Bio Preventive Medicine Corp ROCO:6810
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bio Preventive Medicine (ROCO:6810) Overvalued in 2026?

Based on GuruFocus' analysis, Bio Preventive Medicine stock appears to be undervalued. The current stock price of NT$21.00 is trading 23.7% below its estimated GF Value™ of NT$27.53. GuruFocus considers Bio Preventive Medicine to be Modestly Undervalued.

Key valuation signals for ROCO:6810:

  • Tariff Resilience Score: 0
  • GF Value™: NT$27.53 vs. price of NT$21.00 (23.7% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6810 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio Preventive Medicine Business Description

Address No.18, Taiyuan Street, 1 of 6th Floor, Hsinchu County, Zhubei, TWN, 30265
Bio Preventive Medicine Corp is a clinical-stage biotech company, focusing on the early detection and prevention of diseases specialty of those high value-added molecular diagnostic products.
52GF Score

Get the complete analysis for ROCO:6810

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$21.00
Price
NT$27.53
GF Value